Switch from warfarin to DOACs to avoid INR monitoring exposure

Haematologists could consider switching some patients on warfarin to a DOAC in order to reduce the need for INR monitoring and with it, potential patient exposure to COVID-19. The British Society for Haematology’s Haemostasis and Thrombosis task force said in a statement that regular INR monitoring of patients on warfarin was an essential part of ...

Already a member?

Login to keep reading.

© 2021 the limbic